Skip to main content
Clinical Trials/CTRI/2024/05/067595
CTRI/2024/05/067595
Not Yet Recruiting
Phase 3

Comparative Clinical Evaluation of the Effectiveness of a Novel Local Drug Delivery Agent Containing Tetracycline HCL Micro-particles vs Tetracyline HCL fibers (Periodontal AB plusTM) in Treatment of Periodontal Pockets in Patients with Chronic Periodontitis - Nil

Mala Dixit Baburaj Primary Investigator0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
Mala Dixit Baburaj Primary Investigator
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Mala Dixit Baburaj Primary Investigator

Eligibility Criteria

Inclusion Criteria

  • 1\) Isolated periodontal pockets 5mm to 7mm deep.
  • 2\) Patients with chronic periodontitis
  • 3\) Patient willing to give the informed consent and willing to comply with the study were selected

Exclusion Criteria

  • 1\) Allergy or hypersensitivity to tetracycline or related compounds.
  • 2\) Use of antibiotics within last 3 months.
  • 3\) Patients not maintaining satisfactory oral hygiene after phase1 periodontal therapy.
  • 4\) Systemic diseases.
  • 5\) Pregnancy.
  • 6\) Smoking

Outcomes

Primary Outcomes

Not specified

Similar Trials